Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

At-home vaginal infection test: Combe Inc.'s Vagisil Screening Kit, an in-home testing kit to help women identify vaginal infections, hit store shelves earlier this month. Retailing for $16.99 at food, drug and mass merchandise stores, the product is intended for use by women experiencing itching, burning, unpleasant odor or unusual discharge. The kit contains two individually wrapped vaginal wands with pH paper to help a woman determine her type of infection. In 2006, Fem-V came out with a similar item in the form of a panty liner (1"The Tan Sheet" July 3, 2006, p. 10)...

You may also be interested in...



L’Oréal’s Anthelios SX Will Launch Following FDA Approval Of UVA Filter

L'Oréal will introduce Anthelios SX, the first product on the U.S. market containing a sun filter for short UVA wave protection, this fall, the company announced July 24

NACDS In Brief

Aleve liqui-gels: Bayer's launch of Aleve liqui-gels demonstrates the growing popularity of the formulation on the market. The product, which contains naproxen sodium 220 mg, will make its marketplace debut in 20-, 40- and 80-count packages in January 2007, the firm announces at the National Association of Chain Drugstores Marketplace conference and tradeshow in San Diego, Calif. June 24-27. A TV and print ad campaign will support the launch, Bayer says. Aleve currently is available in tablets, caplets and gelcaps. Wyeth's Advil liqui-gels saw a 25% sales increased in early 2005, despite concerns about NSAID use (1"The Tan Sheet" July 25, 2005, p. 5)...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100528

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel